R1 RCM Sets July 31 Deadline for Takeover Bids
Express News | R1 RCM: Sets Final Deadline for Interested Parties to Submit Fully-Financed Bids on July 31 in Connection With Review Process
Express News | R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives
Hold Rating Maintained Amid R1 RCM Acquisition Uncertainties and Market Reactions
Unveiling 8 Analyst Insights On R1 RCM
Canaccord Genuity Maintains Buy on R1 RCM, Maintains $15 Price Target
Bullish Outlook: Buy Rating on R1 RCM Amid Takeover Interest and Strong Market Position
RBC Capital Keeps Their Buy Rating on R1 RCM (RCM)
TowerBrook, CD&R in Advanced Talks to Make Offer for Health IT Firm R1 RCM
Express News | Tcp-Asc Achi Series Lllp Says on July 8, Partnership Was Advised That R1 RCM, Had Approved Standstill Waiver Request
Express News | Tcp-Asc Achi Series Lllp: Currently in Advanced Discussions to Finalize Proposal at Price Level Above Coyco Proposal to R1 RCM Inc - SEC Filing
Express News | Tcp-Asc Achi Series Lllp Says Partnership Has Aligned With Clayton, Dubilier & Rice to Make Joint Proposal for R1 RCM
R1 RCM Focus of Rival Takeover Bid by TowerBrook, CD&R - Report
S&P 500 Futures Rise In Premarket Trading; CrowdStrike Holdings, Autoliv Lag
Express News | R1 RCM to Release Second Quarter 2024 Results on August 7, 2024
Unusual Options Activity: XOM, SBUX and Others Attract Market Bets, XOM V/OI Ratio Reaches 100.0
EST Jul 11th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Evercore Maintains R1 RCM(RCM.US) With Hold Rating, Maintains Target Price $14
Evercore analyst Elizabeth Anderson CFA maintains $R1 RCM(RCM.US)$ with a hold rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 37.7% and a
TD Cowen Maintains R1 RCM(RCM.US) With Buy Rating, Maintains Target Price $20
TD Cowen analyst Charles Rhyee maintains $R1 RCM(RCM.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 46.5% and a total
Analysts' Opinions Are Mixed on These Healthcare Stocks: R1 RCM (RCM) and AbbVie (ABBV)
Deutsche Bank Raises R1 RCM's Price Target to $16 From $14, Maintains Hold Rating